|
|
|
|
In order to ensure the success of your regulatory submission, whether it is to initiate clinical trials or for commercialization, it's critical that you employ an analytical laboratory that fully understands the chemistry of the products, the real world requirements and pressures on the biopharmaceutical companies, and the current state of regulatory requirements world-wide.
From the very beginning of the biotechnology industry WindRose scientists have been designing and implementing the analytical and quality control programs used for the industry’s most successful therapeutic proteins.
WindRose Analytica is now operating as a division of Althea. Please click here to see our full portfolio of capabilities.
|
|
|
|
|
|
|
|
|
|
Download a copy of Dr. Herman’s presentation on Aggregation and Change Implementation: Causes, Impact and Advances in Characterization Technology at the “Comparability for Biologics, 2008” meeting In Dublin, Ireland. |
|
|
|
|
|
Join us at these fall and winter meetings: AAPS Conference, Seattle, June 22-23; Contract Pharma Contracting & Outsourcing Conference, New Brunswick, Sept. 24-25; BioProcess Intl. Conference, Raleigh, Oct. 12-15; AAPS Annual Meeting, Los Angeles, Nov. 8-12. |
|
|
|
|
|
We have, once again, upgraded our light scattering instrumentation. Light scattering data can be used to improve your purification process as well as your formulation. Light scattering conjugate analysis is useful for characterizing your glycosylated or PEGylated protein.
|
|
|
|
|
|